Full Library

Return to list of results

Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients: Prevention, Diagnosis, and Treatment

RIS

Recommended format for most reference management software

BibTeX

Recommended format for BibTeX-specific software

Open in Zotero
View on zotero.org
Resource type
Book Section
Authors/contributors
Title
Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients: Prevention, Diagnosis, and Treatment
Abstract
Human herpesvirus 5, better known as cytomegalovirus (CMV), infects 50–90% of the adult population worldwide and is the most common opportunistic infection in allogeneic hematopoietic stem cell transplant (HSCT) recipients, causing significant morbidity and mortality [1–6]. Without prophylaxis, CMV reactivation occurs in up to 70–80% of CMV-seropositive individuals [6–9]. This chapter will review the current understanding of CMV infection in HSCT recipients focusing on emerging concepts and updated recommendations for CMV prevention, diagnosis, and management.
Book Title
Emerging Transplant Infections
Date
2021
Publisher
Springer International Publishing
Place
Cham
Pages
573-616
ISBN
978-3-030-01751-4
URL
http://link.springer.com/10.1007/978-3-030-01751-4_25-1
Accessed
10/23/21, 9:33 AM
Short Title
Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
Language
en
Library Catalog
DOI.org (Crossref)
Extra
DOI: 10.1007/978-3-030-01751-4_25-1
Citation
Camargo, J. F. (2021). Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients: Prevention, Diagnosis, and Treatment. In M. I. Morris, C. N. Kotton, & C. Wolfe (Eds.), Emerging Transplant Infections (pp. 573–616). Springer International Publishing. https://doi.org/10.1007/978-3-030-01751-4_25-1
TEXTBOOKS
ORGANISMS
Link to this record
https://www.transplantid.net/RNZ6SKR2